Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 45, Issue 11 (Nov 2007)

Issues

Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor

Markus Schmidt
  • 1Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
/ Canan Dogan
  • 2Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
/ Cahid Birdir
  • 3Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
/ Rainer Callies
  • 4Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
/ Ulrich Kuhn
  • 5Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
/ Alexandra Gellhaus
  • 6Institute for Anatomy, University of Duisburg-Essen, Essen, Germany
/ Alfred Janetzko
  • 7DRG Instruments GmbH, Marburg, Germany
/ Rainer Kimmig
  • 8Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
/ Sabine Kasimir-Bauer
  • 9Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany
Published Online: 2007-10-31 | DOI: https://doi.org/10.1515/CCLM.2007.316

Abstract

Background: Decreased concentrations of the circulating angiogenic factors, free placental growth factor (PLGF) and free vascular endothelial growth factor (VEGF), and increased concentrations of the anti-angiogenic factor, soluble fms-like tyrosine kinase 1 (sFLT-1) have been observed during clinical preeclampsia. We established a new PLGF-ELISA kit for the measurement of PLGF in sera. In the present study, we demonstrated the assay characteristics by measurement of PLGF expression in normal and preeclamptic pregnancies as compared to an established research kit.

Methods: Blood samples were taken from 64 women with singleton uncomplicated pregnancies for longitudinal measurement of PLGF in the course of pregnancy. In 30 preeclamptic patients, serum levels of PLGF and sFLT-1 were measured by Human PLGF-ELISA and Human sVEGF R1 ELISA according to the described test principles. The assay characteristics of the new PLGF-ELISA were determined and the results were compared to those performed with an available research kit.

Results: The PLGF concentration in normal pregnancies showed a steady increase starting at the beginning of the second trimester with a peak at 28–32 weeks and a consistent decline thereafter. The preeclamptic pregnancies had significant lower serum concentrations of PLGF and significant higher serum concentrations of sFLT-1 as compared to the non-preeclamptic pregnancies. All the measured assay characteristics fulfilled the required specifications. Comparison of the values of the new PLGF-ELISA and the established research kit resulted in a correlation coefficient of 0.921.

Conclusions: Our results support the hypothesis that an imbalance between factors promoting angiogenesis, such as PLGF, and factors antagonizing angiogenesis, such as sFLT-1, has a fundamental role in the pathogenesis of preeclampsia. The new established ELISA test can be considered reliable and it offers many advantages. As it is authorized for routine diagnostic testing, it may offer new possibilities in the prediction of preeclampsia in clinical routine.

Clin Chem Lab Med 2007;45:1504–10.

Keywords: angiogenesis; fms-like tyrosine kinase; pathophysiology; placental growth factor; preeclampsia; vascular endothelial growth factor

About the article

Corresponding author: Dr. Markus Schmidt, MD, Department of Gynecology and Obstetrics, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany Phone: +49-201-723-85290, Fax: +49-201-723-5962


Received: 2007-05-15

Accepted: 2007-07-23

Published Online: 2007-10-31

Published in Print: 2007-11-01


Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: https://doi.org/10.1515/CCLM.2007.316.

Export Citation

Comments (0)

Please log in or register to comment.
Log in